Cargando…
Hepatitis C and renal transplantation in era of new antiviral agents
Data from World Health Organization estimates that the hepatitis C virus (HCV) prevalence is 3% and approximately 71 million persons are infected worldwide. HCV infection is particularly frequent among patients affected by renal diseases and among those in dialysis treatment. In addition to produce...
Autores principales: | Salvadori, Maurizio, Tsalouchos, Aris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107518/ https://www.ncbi.nlm.nih.gov/pubmed/30148074 http://dx.doi.org/10.5500/wjt.v8.i4.84 |
Ejemplares similares
-
Microbiota, renal disease and renal transplantation
por: Salvadori, Maurizio, et al.
Publicado: (2021) -
Biomarkers in renal transplantation: An updated review
por: Salvadori, Maurizio, et al.
Publicado: (2017) -
Therapeutic apheresis in kidney transplantation: An updated review
por: Salvadori, Maurizio, et al.
Publicado: (2019) -
Current protocols and outcomes of ABO-incompatible kidney transplantation
por: Salvadori, Maurizio, et al.
Publicado: (2020) -
Innovative immunosuppression in kidney transplantation: A challenge for unmet needs
por: Salvadori, Maurizio, et al.
Publicado: (2022)